Kamada earnings were $19.0M for the trailing 12 months ending Jun 30, 2025, with 17.9% growth year over year. The latest KMDA earnings report on Jun 30, 2025 announced Q2 2025 earnings of $7.4M, up 86.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, KMDA reported annual earnings of $14.5M, with 74.6% growth.
KMDA past earnings growth
How has KMDA's earnings growth performed historically?
On KMDA's earnings call on Invalid Date, Kamada (NASDAQ: KMDA) reported Q2 2025 earnings per share (EPS) of $0.13, up 62.5% year over year. Total KMDA earnings for the quarter were $7.38 million. In the same quarter last year, Kamada's earnings per share (EPS) was $0.08.
As of the last Kamada earnings report, Kamada is currently profitable. Kamada's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $19.01 million, a 26.13% increase year over year.
What was KMDA's earnings growth in the past year?
As of Kamada's earnings date in Invalid Date, Kamada's earnings has grown 17.86% year over year. This is 10.44 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 28.3%. KMDA earnings in the past year totalled $19.01 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.